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Abstract
Background: Autonomic neuropathy is a common and serious complication of diabetes. 
Early detection is essential to enable appropriate interventional therapy and management. 
Dynamic pupillometry has been proposed as a simpler and more sensitive tool to detect 
subclinical autonomic dysfunction. The aim of this study was to investigate pupil 
responsiveness in diabetic subjects with and without cardiovascular autonomic 
neuropathy (CAN) using dynamic pupillometry in two sets of experiments.
Methods: During the first experiment, one flash was administered and the pupil response 
was recorded for 3 s. In the second experiment, 25 flashes at 1-s interval were administered 
and the pupil response was recorded for 30 s. Several time and pupil-iris radius-related 
parameters were computed from the acquired data. A total of 24 diabetic subjects (16 
without and 8 with CAN) and 16 healthy volunteers took part in the study.
Results: Our results show that diabetic subjects with and without CAN have sympathetic 
and parasympathetic dysfunction, evidenced by diminished amplitude reflexes and 
significant smaller pupil radius. It suggests that pupillary autonomic dysfunction occurs 
before a more generalized involvement of the autonomic nervous system, and this could 
be used to detect early autonomic dysfunction.
Conclusions: Dynamic pupillometry provides a simple, inexpensive, and noninvasive tool 
to screen high-risk diabetic patients for diabetic autonomic neuropathy.
Background
Diabetic autonomic neuropathy (DAN) is the least recognized and understood complica-
tions of diabetes, despite its significant negative impact on survival and quality of life in
people with diabetes [1]. It can involve the entire autonomic nervous system. Among the
most serious DAN is cardiovascular autonomic neuropathy (CAN), which encompasses
damage to the autonomic nerve fibers that innervate the heart, affecting heart rate and
blood pressure control and vascular dynamics. Diabetes-related CAN occur in one-quarter
of the subjects with Type 1 diabetes and in one-third of those with Type 2 diabetes. CAN is
associated with increased mortality, silent myocardial ischemia, and may even predict the
development of stroke [2]. While DAN can be clinically evident, manifested by dysfunction
of one or more organ systems (e.g. cardiovascular, gastrointestinal, genitourinary, sudomo-
tor, or ocular) [3], it is frequently subclinical and asymptomatic.
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Page 2 of 16A recent statement of the ADA [4] concerning diabetic neuropathies recommends that
screening should be instituted at diagnosis of Type 2 diabetes and 5 years after the diag-
nosis of Type 1 diabetes. Screening might comprise a history and an examination for the
signs of autonomic dysfunction. Earlier identification of these high-risk individuals is
clearly important, as it would allow for the deployment of management strategies to
improve long-term outcomes. If diagnosis is delayed until the development of symp-
toms, the outcome is extremely poor, with a 5-year survival rate of only 50% [5].
Although several conventional autonomic function tests exist to aid clinicians in the
evaluation of DAN, they require specific equipments and well-trained personnel, and are
time-consuming to perform [6]. Additionally, these tests typically require active patient
participation and compliance, leading to their use in a minority of subjects, mainly those
with advanced autonomic neuropathy who have already developed symptoms. There-
fore, the development of new approaches for the early identification of DAN, i.e., before
the onset of symptoms, is desired. This would allow for interventions and management
that may result in reduced long-term complications, as previously reported [7]. In this
context, simple and inexpensive approach to screen large number of subjects with diabe-
tes for autonomic neuropathy would be valuable to minimize the enormous social and
economic burden caused by DAN, especially for subjects at a much higher risk, such as
those with undiagnosed CAN. The pupil dynamics analysis, i.e., dynamic pupillometry,
has the potential for supporting such a screening approach.
Pupil size, shape, and reactivity to light have been used as indicators of neurological
function in brain-injured patients, particularly in comatose patients. There are circular
and radial muscles that control the size of the pupil. The former is innervated by para-
sympathetic fibers, and the latter, by sympathetic fibers. Thus, the pupil radius is con-
trolled by both the sympathetic and parasympathetic autonomic nervous system in
response to environmental light, a mechanism called the pupil light reflex. Therefore,
the pupillary radius response to an external light stimulus might provide an indirect
means to assess the integrity of neuronal pathways controlling pupil size [8] and an early
indication of DAN [9].
Sympathetic stimulation of α-1 adrenergic receptors causes the contraction of the
radial muscle, and subsequent dilatation of the pupil (mydriasis). Conversely, parasym-
pathetic stimulation causes contraction of the circular muscle and constriction of the
pupil (miosis). The pupillary reflex is mediated by acetylcholine and noradrenaline, caus-
ing miosis and mydriasis, respectively. Thus, change in pupil size in response to a light
stimulus is based on a functional equilibrium between sympathetic and parasympathetic
activity [10].
It is therefore reasonable to expect that generalized conditions of the autonomic sys-
tem will affect the pupil response to the light stimulus [11]. Parasympathetic dysfunction
might cause relative mydriasis of the pupil in light conditions and diminished constrictor
reflexes with or without pupillotonia, which is thought to result from aberrant re-inner-
vations. Sympathetic dysfunction might cause relative miosis of the pupil in the dark,
increased re-dilatation lag, and attenuation of the startle reflex, as observed in Horner's
syndrome [12]. Investigations in subjects with diabetes have revealed abnormal
responses of the pupil-radius modulation in some subjects, especially in those with dia-
betic neuropathy [9,13-18], supporting the potential of pupillometry to be used as a
screening tool for autonomic neuropathy in the diabetic population [15-17].
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Page 3 of 16Previous studies have described the resting pupil radius as a sympathetic parameter,
and the reflex amplitude as a parasympathetic parameter in healthy and diabetic subjects
[9,13-18]. However, there is very little evidence with regard to the relationship between
the pupil-iris ratio and other time-related parameters with autonomic neuropathy in dia-
betes subjects with and without CAN. In this study, the results of an investigative study
of the pupil responsiveness to light flashes in healthy and diabetic subjects with and
without clinical evidence of CAN has been presented. The study was performed with a
custom-built dynamic pupillometer [19] that allows the computation of a larger number
of parameters when compared with commercially available pupillometers.
Methods
Subjects
This study comprised three groups: Group 1 - 16 healthy volunteers (9 males and 7
females); Group 2 - 16 diabetic subjects without CAN (15 males and 1 females); and
Group 3 - 8 diabetic subjects with CAN (7 males and 1 females). The study was con-
ducted in the Diabetes Centre, Royal Hallamshire Hospital, University of Sheffield, UK.
Informed consent was obtained from all participants. Subjects were not receiving any
drugs affecting sympathetic or parasympathetic pupillary function, and those with past
history of ocular operations, nonsymmetrical pupil, misshapen pupil, or conditions
affecting pupillary reflexes were excluded [20]. All diabetic subjects underwent standard
blood and biochemical laboratory tests.
Owing to the experiment setup, only the right side of each participant was accessible
for pupillometry. The pupil reaction was assessed twice: first with one flash, and 5 min
later with 25 flashes. Both tests were performed in the right eye, and all the subjects were
tested between 9 and 12 am. For all patients, at least 8 h of sleep was required in the pre-
ceding night without any hypoglycemic episode.
The pupil stimulator and response recorder
Figure 1 illustrates the setup of the instrument, named Pupil Stimulator and Response
Recorder (PSRR), developed to stimulate and record the pupil response to flashes of
white light [19]. It consisted of a commercial monochromatic CCD analog video camera
(EIA-RS-170 standard) that captures an image frame every 1/30 seconds; four infrared
(IR) light emitter diodes (LEDs) with a diameter of 5 mm; five high-intensity bright white
Figure 1 Setup of the Pupil Stimulator and Response Recorder (PSRR) instrument developed to per-
form in vivo experiments.
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Page 4 of 16LEDs with a diameter of 8 mm; a 17-cm height aluminum cone section with extremity
diameters of 14.5 and 5.6 cm; an electronic current supply to the LEDs; a built unit for
timing control based on the microcontroller PIC16F873 (Microchip Technology Inc.,
Arizona, USA); and a Pentium IV 3 GHz Notebook with a PCMCIA frame grabber to
record and process the pupil images. The aluminum cone was fixed in a printed circuit
board (that hold the IR and white LEDs), which was then fixed in the CCD camera. The
IR and the high-intensity bright white LEDs were symmetrically placed around the CCD
lens, as illustrated in Figure 1. The IR LEDs promoted the illumination with a high pupil
to iris contrast, but without producing any pupil response. The lens focus was manually
adjusted by rotating the aluminum cone. The pupil and the aluminum cone wall acted as
a mirror, reflecting the IR LEDs light. The light reflection in the cone wall caused too
many artifacts in the pupil image, making the pupil-iris edge detection difficult during
the image processing phase. To avoid these artifacts, the aluminum cone interior was
blackened.
The PSRR can stimulate the pupil with one flash or a series of 25 flashes (1-Hz fre-
quency), with fixed intensity (250 cd) and duration (10 ms). The changes in the radius of
the pupil were evaluated as a function of several time-dependent and pupil-iris radius
ratio parameters.
The pupil radius was automatically determined for each frame in the recorded video
stream. The offline image processing algorithm was implemented using MATLAB (The
MathWorks Inc., Massachusetts, USA) environment and was divided into three major
steps: elimination of the IR LEDs light reflex within the pupil; enhancement of the image
borders; and pupil and iris edge detection.
Figure 2 shows the images obtained in some of the major algorithms steps until the
best circle that fits the pupil is found. Figure 2(a) shows the region of interest (ROI) that
is cropped from the original image. First, the IR LED light reflection was detected using
the Canny edge detector with a threshold set to 0.8. The detector returned one pixel line
that makes a frontier between the white reflected and the dark pupil regions. These con-
tours were then filled, forming a reference mask to change the white pixel in the pupil by
a gray value of 35. It is important to note that owing to our image acquisition system cap-
turing the eye images under the same illumination condition, the pupil darkness of every
subject has a gray value around 35. Figure 2(b) and 2(c) shows the mask and the eye
image with the IR LED light reflection removed. This image was then edge enhanced
using a high-boost filtering [21], followed by an intensity transformation through a 0.6-
gamma function. The result is shown in Figure 2(d). A Canny edge detector with a 0.5-
threshold was then applied to find the frontier pixels between the pupil and iris, as
shown in Figure 2(e). To determine the pupil radius, it was found that the best solution
was by convolving the image shown in Figure 2(e) with contour circle masks with differ-
ent radius (20-90 pixels, with 0.2 pixels of resolution), and determining the circle radius
that gives the maximum correlation.
This algorithm was even able to determine the pupil radius in those cases where the
pupil was under the eyelid or eyelashes, as shown in Figure 3(a) and 3(b).
The iris radius was automatically determined for each frame in the recorded video
stream using the Hough Transform, followed by a canny edge detector algorithm [21].
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Page 5 of 16Experiments
All the subjects underwent two experiments. In the first experiment, the subject dark-
adapted for 2 min leaning on the cone before a single light flash was administered. The
pupil response was recorded for 3 s. During this period, the subject was instructed to
avoid or minimize blinking.
Figure 2 Pupil radius measurement sequence. (a) ROI selected manually by the user; the four brighter re-
gions in the image correspond to the IR LEDs light reflected by the retina; (b) Image mask with pixels values set 
to white in the position of the IR LEDs light reflected; (c) the ROI in (a) with the corresponding white pixels in 
(b) set to a gray level of 35; (d) result of edge enhancement and scale transformed of (c); (e) pupil edge; and (f) 
the circle that gives the maximum correlation with the pupil border in (d) over the ROI processed image in (d).
Figure 3 Pupil-radius determination with the eyelid (a) and eyelashes (b) over the pupil.
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administered at 1-s interval. The pupil response was recorded for 30 s. In both the exper-
iments, the other eye was covered with a black fabric to avoid any external light interfer-
ence.
Single light flash parameters
Figure 4 shows a typical pupil response obtained from a healthy volunteer. It shows the
radius of the pupil in each captured frame in pixels as a function of time.
The pupil reflex evaluation parameters can be defined as follows [10]:
• Pupil-iris radius ratio in the frame preceding the flash, #7 in Figure 4, divided by iris
radius;
• Latency from flash exposure to the start of constriction (when pupil radius
decreases to 90% of pre-flash value), #2 in Figure 4;
• Pupil-iris radius ratio (#6 in Figure 4 divided by iris radius) and latency (#4 in Figure
4) to the smallest size of the pupil;
• During the recovery phase: pupil-iris radius ratio (#5 in Figure 4 divided by iris
radius) and latency to plateau at 75% of pre-flash pupil radius (#1 in Figure 4);
• Duration of constriction (#3 in Figure 4);
• Reflex amplitude - resting pupil radius (#7 in Figure 4) minus minimum pupil
radius after the light stimulus (#6 in Figure 4);
• Velocity of constriction - changing rate in the pupil radius over the reflex amplitude
time interval: reflex amplitude divided by #3 in Figure 4.
Twenty-five light flashes parameters
Figure 5 shows a typical pupil response obtained from a healthy volunteer. It shows the
radius of the pupil in pixels for each captured frame as a function of time and the main
parameters measured.
Figure 4 Typical pupil reflex of a healthy volunteer after a 10-ms light flash intensity of 250 cd was trig-
gered at zero second. The indicated parameters are defined as follows: 1-Latency time to reach the plateau 
at 75% of pre-flash pupil radius; 2-Latency time to the beginning of constriction; 3-Duration of constriction; 4-
Latency to the largest constriction; 5- Radius of pupil on reaching the plateau; 6-Radius of pupil at largest con-
striction; 7- Radius of pupil before flash.
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Page 7 of 16For the 25-flashes experiment, the pupil reflex evaluation parameters can be defined as
follows [10]:
• Pupil-iris ratio in the frame preceding the 10th (#3 in Figure 5 divided by iris radius)
and 25th flash (#5 in Figure 5 divided by iris radius);
• Pupil-iris ratio of the smallest size of the pupil after the 10th (#4 in Figure 5 divided
by iris radius) and 25th flash (#6 in Figure 5 divided by iris radius);
• Latency from flash exposure to the start of constriction after the 10th and 25th flash;
• Latency to the smallest size of the pupil after the 10th and 25th flash;
• During the recovery phase: pupil-iris ratio (#7 in Figure 5 divided by iris radius) and
latency to plateau when the pupil radius reaches 75% of the pre-flash value;
• Duration of constriction.
Assessment for CAN
A standardized set of cardiovascular tests was used to assess the prevalence of CAN. The
tests were performed after a resting period of 10 min to ensure that the heart rate was at
its baseline values. The tests included recording the electrocardiogram (ECG) to deter-
mine the heart rate variability (HRV), and measurements of systolic and diastolic blood
pressure (BP). Four tests of HRV and one test of BP control were performed and evalu-
ated according to standard criteria [22]. Recordings were carried out at rest (HRV and
BP), deep breathing (HRV), Valsalva maneuver (HRV), and active standing up (HRV and
BP). The total duration of these tests was approximately 30 min. Diabetic subjects were
classified as having CAN if the results of two or more of these five autonomic function
tests were below age-adjusted normative values [22].
Statistical analysis
Statistical analysis for all the variables included the calculation of mean and standard
deviation (SD). One-way ANOVA and post-hoc Bonferroni statistical tests were used to
Figure 5 Typical pupil reflex of a healthy volunteer in the experiment with a series of 25 flashes at 1-s 
intervals. The indicated parameters are defined as follows: 1- Radius of pupil before the first flash; 2- Radius of 
pupil at largest constriction after the first flash; 3- Radius of pupil before the 10th flash; 4- Radius of pupil at larg-
est constriction after the 10th flash; 5- Radius of pupil before the 25th flash; 6- Radius of pupil at largest constric-
tion after the 25th flash; 7-Radius of pupil on reaching the plateau at 75% of pupil radius preceding the 25th flash.
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Page 8 of 16compare the pupillography results between the groups. Comparisons involving the dia-
betes group (without CAN vs. with CAN) were carried out using Kruskal-Wallis Test.
SPSS version 15.0 (SPSS Inc., Chicago, USA) was used to analyze the data, and p values
less than 0.05 were considered statistically significant.
Results
Single light flash experiment
The mean and SD values for each parameter used to evaluate the response of the pupil
reaction to a single flash and the statistical significance tests are shown in Table 1.
There was no significant difference between the three groups with regard to age (p >
0.05). The duration of diabetes did not differ in the diabetic subjects with (22 ± 10 years
Table 1: Subjects' baseline characteristics and pupillometry parameters
Parameters Healthy Volunteers Diabetes p values
Without CAN With CAN p1 p2 p3
Number of subjects 16 16
(9 Type 1, 7 Type 2)
8
(3 Type 1, 5 Type 2)
- - -
Gender (M/F) 9/7 15/1 7/1 - - -
Age (years) 44 ± 13 50 ± 11 51 ± 5 ns ns ns
Duration of diabetes 
(years)
- 20 ± 10 22 ± 10 - - ns
HbA1c (%) - 8.3 ± 1.1 9.4 ± 2.2 - - ns
Systolic blood pressure 
(mmHg)
120 ± 13 141 ± 20 147 ± 16 * * ns
Diastolic blood pressure 
(mmHg)
74 ± 6 77 ± 9 87 ± 10 ns * ns
Ratio P/I in darkness 0.55 ± 0.056 0.42 ± 0.045 0.35 ± 0.077 $ $ *
Latency to constriction (s) 0.20 ± 0.078 0.26 ± 0.070 0.29 ± 0.100 ns * ns
Ratio P/I at largest 
constriction
0.40 ± 0.050 0.30 ± 0.031 0.26 ± 0.065 $ $ ns
Latency to largest 
constriction (s)
0.90 ± 0.147 1.01 ± 0.192 0.91 ± 0.089 ns ns ns
Reflex amplitude (pixels) 9.62 ± 1.99 7.40 ± 1.90 5.35 ± 2.14 # # ns
Ratio P/I of plateau 0.50 ± 0.055 0.37 ± 0.046 0.32 ± 0.068 $ $ ns
Latency to plateau (s) 1.88 ± 0.539 1.95 ± 0.744 1.49 ± 0.331 ns ns ns
Duration of constriction (s) 1.63 ± 0.559 1.69 ± 0.75 1.19 ± 0.318 ns ns ns
Velocity of constriction 
(pixels/s)
14.57 ± 5.32 10.28 ± 3.49 7.87 ± 3.48 * # ns
[mean ± standard deviation] for the single flash experiment. p1 - Comparison between healthy volunteers 
and diabetic subjects without CAN. p2 - Comparison between healthy volunteers and diabetic subjects with 
CAN. p3 - Comparison between diabetic subjects without and with CAN. ns - not significant, * - p < 0.05, # - 
p < 0.01, and $ - p < 0.001.
Ferrari et al. BioMedical Engineering OnLine 2010, 9:26
http://www.biomedical-engineering-online.com/content/9/1/26
Page 9 of 16[mean ± SD]) and without CAN (20 ± 10 years), and HbA1c (%) was not significantly dif-
ferent between these two groups (9.4 ± 2.2 and 8.3 ± 1.1, respectively).
Systolic blood pressure was significantly lower (p < 0.05) in healthy volunteers (120 ±
13 mmHg) when compared with diabetic subjects without CAN (141 ± 20 mmHg) and
diabetic subjects with CAN (147 ± 16 mmHg). Moreover, diastolic blood pressure was
significantly greater (p < 0.05) in diabetic subjects with CAN (87 ± 10 mmHg) than in
diabetic subjects without CAN (77 ± 9 mmHg).
Table 1 indicates that the pupil-iris ratio in the frame preceding the light flash was sig-
nificantly greater (p < 0.001) in healthy volunteers (0.55 ± 0.056 [mean+SD]) than in dia-
betic subjects without CAN (0.42 ± 0.045) and diabetic subjects with CAN (0.35 ±
0.077). The remarkable difference in the pupil size in darkness can be seen in Figure 6
which shows the images of a healthy volunteer (a), diabetic subject without CAN (b), and
diabetic subject with CAN (c). In Figure 6, the four white spots within the pupil are the
reflecting IR LEDs used to illuminate the eye during image recording.
Latency from flash exposure to the start of constriction was significantly longer (p <
0.01) in the diabetic subjects with CAN (0.29 ± 0.100 s) than in healthy volunteers (0.20
± 0.078 s).
Similarly, the pupil-iris ratio in the frame of largest constriction was significantly
greater (p < 0.001) in healthy volunteers (0.40 ± 0.050) than in diabetic subjects without
CAN (0.30 ± 0.031) and with CAN (0.26 ± 0.065).
However, the latency to the largest constriction of the pupil was not significantly dif-
ferent between the groups.
The difference in the pupil size in the frame of largest constriction is illustrated in Fig-
ure 7 which shows the images of healthy volunteer (a), diabetic subject without CAN (b),
and diabetic subject with CAN (c).
During the recovery phase, pupil-iris ratio in the plateau was significantly greater (p <
0.001) in healthy volunteers (0.50 ± 0.055) than in diabetic subjects with CAN (0.32 ±
0.068) and diabetic subjects without CAN (0.37 ± 0.046).
No significant differences were found between the groups in the latency to reach the
plateau and duration of constriction.
Reflex amplitude measured in pixels was significantly higher (p < 0.01) in healthy vol-
unteers (9.62 ± 1.99) when compared with diabetic subjects without CAN (7.40 ± 1.90)
and diabetic subjects with CAN (5.35 ± 2.14). Moreover, the velocity of constriction (pix-
els/s) was significantly higher (p < 0.05) in healthy volunteers (14.57 ± 5.32) when com-
Figure 6 Recorded IR-illuminated images of the eye of three subjects showing the pupil at its maxi-
mum mydriasis for (a) healthy volunteer, (b) diabetic subject without CAN, and (c) diabetic subject 
with CAN.
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Page 10 of 16pared with diabetic subjects without CAN (10.28 ± 3.49) and diabetic subjects with CAN
(7.87 ± 3.48).
No significant difference was found between the diabetic groups, with exception for
the P/I ratio in darkness.
Figure 8 shows a comparison of the mean and SD of the pupil-iris ratios among the
three groups.
Twenty-five light flashes experiment
In the second experiment, one diabetic subject without CAN and three diabetic subjects
with CAN blinked more than three times during the experiment and were excluded.
Figure 8 Comparison of mean and standard deviation values of the pupil-iris ratio (P/I) in the largest 
mydriasis before flash (#7 in Figure 4), at largest miosis (#6 in Figure 4), and during the plateau period 
(#5 in Figure 4). These values were obtained after one 10-ms light flash in healthy volunteers and diabetic sub-
jects with and without CAN.
Figure 7 Recorded IR-illuminated images of the eye of three subjects showing the pupil at its maxi-
mum miosis for (a) healthy volunteer, (b) diabetic subject without CAN, and (c) diabetic subject with 
CAN.
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Table 2: Subjects' baseline characteristics and pupillometry parameters
Flash Parameters Healthy Volunteers Diabetic p values
Without CAN With CAN p1 p2 p3
Number of subjects 16 15
(9 Type 1, 7 Type 2)
5
(2 Type 1, 3 Type 2)
- - -
Gender (M/F) 9/7 14/1 4/1 - - -
Age (years) 44 ± 13 51 ± 11 49 ± 4 ns ns ns
Duration of diabetes (years) - 20 ± 11 20 ± 15 - - ns
HbA1c (%) - 8.3 ± 1.1 10.2 ± 2.1 - - ns
Systolic blood pressure (mmHg) 120 ± 13 143 ± 20 145 ± 14 * * ns
Diastolic blood pressure (mmHg) 74 ± 6 78 ± 9 86 ± 8 ns * ns
10th Ratio P/I preceding the 10th flash 0.33 ± 0.050 0.26 ± 0.024 0.28 ± 0.071 $ ns ns
Latency to constriction (s) 0.35 ± 0.139 0.42 ± 0.126 0.44 ± 0.192 ns ns ns
Latency to largest constriction (s) 0.68 ± 0.165 0.75 ± 0.133 0.68 ± 0.293 ns ns ns
Ratio P/I at largest constriction 0.28 ± 0.049 0.24 ± 0.021 0.27 ± 0.076 * ns ns
25th Ratio P/I preceding the 25th flash 0.32 ± 0.044 0.26 ± 0.022 0.30 ± 0.062 # ns ns
Latency to constriction (s) 0.31 ± 0.125 0.36 ± 0.070 0.40 ± 0.155 ns ns ns
Ratio P/I at largest constriction 0.27 ± 0.046 0.23 ± 0.020 0.25 ± 0.063 ns ns ns
Latency to largest constriction (s) 0.69 ± 0.123 0.72 ± 0.054 0.79 ± 0.138 ns ns ns
Ratio P/I of plateau 0.30 ± 0.041 0.25 ± 0.021 0.28 ± 0.060 $ ns ns
Latency to plateau (s) 0.95 ± 0.168 0.95 ± 0.082 1.35 ± 0.583 ns # #
Duration of constriction (s) 0.64 ± 0.237 0.59 ± 0.145 0.95 ± 0.675 ns ns ns
[mean ± standard deviation] for the 25 flashes experiment. p1 - Comparison between healthy volunteers and diabetic subjects without CAN. p2 - Comparison between healthy volunteers and 
diabetic subjects with CAN. p3 - Comparison between diabetic subjects without and with CAN. ns - not significant, * - p < 0.05, # - p < 0.01, and $ - p < 0.001.
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0.05). The duration of diabetes did not differ in the diabetic subjects with (20 ± 15 years)
and without CAN (20 ± 11 years), and HbA1c (%) was not significantly different between
these two groups (10.2 ± 2.1 and 8.3 ± 1.1).
Systolic blood pressure was significantly lower (p < 0.05) in healthy volunteers (120 ±
13 mmHg) when compared with diabetic subjects without CAN (143 ± 20 mmHg) and
diabetic subjects with CAN (145 ± 14 mmHg). Moreover, diastolic blood pressure was
significantly greater (p < 0.05) in diabetic subjects with CAN (86 ± 8 mmHg) than in dia-
betic subjects without CAN (78 ± 9 mmHg).
Table 2 shows the mean and SD values of the calculated parameter used to evaluate the
response of the pupil reaction to 25 flashes and the statistical significance tests.
Pupil-iris ratio in the frame preceding the 10th flash was significantly greater (p <
0.001) in healthy volunteers (0.33 ± 0.050) than in diabetic subjects without CAN (0.26 ±
0.024), but no significant difference was found between the healthy volunteers and dia-
betic subjects with CAN.
The latency from the 10th flash exposure to the start of constriction was not signifi-
cantly different between the groups.
There was no difference between the groups in latency to the largest constriction of
the pupil after the 10th flash.
The pupil-iris ratio to the largest constriction was significantly greater (p < 0.05) in
healthy volunteers (0.28 ± 0.049) than in diabetic subjects without CAN (0.24 ± 0.021),
but no significant difference was found between the healthy volunteers and diabetic sub-
jects with CAN.
Figure 9 Comparison of mean and standard deviation values of the pupil-iris ratios (P/I) before the 10th 
flash (#3 in Figure 5) and at the largest constriction (#4 in Figure 5).
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Page 13 of 16For the 10th flash, no significant difference was found between diabetic groups.
The significant differences between groups, in pupil-iris ratios at 10th flash for the sec-
ond experiment, are illustrated in Figure 9.
The pupil-iris ratio one frame before the 25th flash was also significantly greater (p <
0.01) in healthy volunteers (0.32 ± 0.044) than in those diabetic subjects without CAN
(0.26 ± 0.022), but no significant difference was found between the healthy volunteers
and diabetic subjects with CAN.
There were no significant differences between the three groups in latency to constric-
tion at the 25th flash exposure, pupil-iris ratio, and latency to the largest constriction of
the pupil after the 25th flash.
During the recovery phase, the pupil-iris ratio at plateau was significantly greater (p <
0.001) in healthy volunteers (0.30 ± 0.041) than in diabetic subjects without CAN (0.28 ±
0.060), but no significant difference was found between the healthy volunteers and dia-
betic subjects with CAN.
Moreover, the latency to plateau was significantly shorter (p < 0.01) in healthy volun-
teers (0.95 ± 0.168 s) than in diabetic subjects with CAN (1.35 ± 0.583 s).
Figure 10 shows a comparison of the mean and SD of the pupil-iris ratios at the 25th
flash among the three groups.
Duration of the constriction was not significantly different between the three groups.
For the 25th flash, no significant difference was found between the diabetic groups,
with an exception in the latency to plateau.
Figure 10 Comparison of mean pupil-iris ratios (P/I) preceding 25th flash (#5 in Figure 5) and during the 
plateau period (#7 in Figure 5) in healthy volunteers (HV) and diabetic subjects with and without CAN 
(Error bars represent SD).
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The results of the first experiment confirm the findings of previous studies [9,12-15] of a
smaller resting pupil size and smaller reflex amplitude in subjects with diabetes.
According to Smith and Dewhirst [18], the resting pupil size is mainly under sympa-
thetic control and radius reduction is a sign of diminished sympathetic outflow to the iris
muscles. During the constriction phase, radius and time parameters mainly reflect para-
sympathetic function. However, both the systems are active during the recovery phase
[15].
Smith and Smith [13] concluded that decreased reflex amplitudes in diabetic subjects
cannot be ascribed to small pupil radius at rest, but are owing to a parasympathetic dys-
function. From our results in Table 1 comparing healthy volunteers and diabetic subjects
(with and without CAN), a significant reduction in the pupil radius at baseline and
amplitude of the pupil reflexes was found in both the diabetic groups. This might indi-
cate that both sympathetic and parasympathetic dysfunction is affecting the pupillary
reflex in these groups.
The significantly smaller initial pupil size seen in the diabetes group without CAN
when compared with healthy subjects might be regarded as an early sign of involvement
of the autonomic nerve system before cardiac manifestation of systemic autonomic neu-
ropathy [9].
With regard to the second experiment, no comparison with previous findings was pos-
sible because no similar studies have been reported in the literature. The second experi-
ment was found to lead to a gradual increase in the parasympathetic tone as a result of
repeated light stimulation. This condition provides a different level of balance between
parasympathetic and sympathetic nervous system, which is not linearly correlated to
those of the first experiment. Although the two components of the autonomic nervous
system may have abnormal tones, their combination may produce normal results during
the first experiment. Moreover, the pupil muscles may perform well during a single flash
administration, but this may not be true for repeated stimulation. The second experi-
mental condition provided data on the flexibility of the pupil and autonomic nervous
system.
Our results provide novel evidence of the increased prevalence of both parasympa-
thetic and sympathetic autonomic dysfunction in diabetic subjects with and without
CAN, as evidenced by a significant reduction in the pupil-iris ratios and longer latency to
start of constriction at the 10th flash when compared with healthy volunteers. This shows
that dynamic pupillometry may be a valuable tool for the early detection of these abnor-
malities. Failure to show a statistically significant difference between the diabetes groups
in the second experiment may be accounted to the small number of subjects in the CAN
group. There is a need for larger as well as prospective studies to better understand this
relationship.
Dynamic pupillometry is a simple, inexpensive, and quick technique that requires min-
imal specialist training. It has the other added advantage over the battery of cardiovascu-
lar tests currently in use, in that it is not reliant on active subject participation and
compliance. This study also suggests that it is a more sensitive measure of autonomic
dysfunction than the conventional autonomic function tests. It also suggests that pupil-
lary autonomic dysfunction occurs early, before a more generalized impairment of the
autonomic nervous system, in diabetes.
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Page 15 of 16The pupil-iris ratio in darkness and the pupil reflex amplitude seem to be the dynamic
pupillometry parameters most affected by alterations in the autonomic nervous system.
Thus, they might be useful in detecting early autonomic dysfunction in high-risk groups.
Conclusions
In summary, dynamic pupillometry results indicate that this simple and non inexpensive
approach can be used as an aiding tool during the clinical examination carried out in the
general or specialized clinical settings. This method has the potential to significantly
improve the outcome in detecting the early onset of autonomic dysfunction in subjects
with diabetes mellitus.
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